Paul Morrish

2.9k total citations
29 papers, 1.7k citations indexed

About

Paul Morrish is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Morrish has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 6 papers in Psychiatry and Mental health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Morrish's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Paul Morrish is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (12 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Paul Morrish collaborates with scholars based in United Kingdom, Netherlands and Denmark. Paul Morrish's co-authors include David J. Brooks, G. V. Sawle, Dale L. Bailey, James S. Rakshi, Takeshi Uema, Kengo Ito, Karl Friston, John Ashburner, Alain Dagher and I. H. Jenkins and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Paul Morrish

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Morrish United Kingdom 15 1.3k 717 218 207 158 29 1.7k
Ihtsham Haq United States 23 1.1k 0.9× 499 0.7× 219 1.0× 150 0.7× 136 0.9× 68 1.5k
Christopher Kenney United States 21 1.3k 1.1× 749 1.0× 187 0.9× 275 1.3× 56 0.4× 32 2.0k
Lorenzo Kiferle Italy 20 871 0.7× 551 0.8× 184 0.8× 196 0.9× 74 0.5× 30 1.3k
E.M.J. Foncke Netherlands 26 1.3k 1.1× 568 0.8× 327 1.5× 120 0.6× 137 0.9× 45 1.7k
Hisao Tachibana Japan 19 654 0.5× 294 0.4× 327 1.5× 115 0.6× 81 0.5× 68 1.3k
Samer D. Tabbal United States 24 1.2k 1.0× 564 0.8× 169 0.8× 83 0.4× 71 0.4× 39 1.5k
R. Hilker Germany 16 701 0.6× 346 0.5× 204 0.9× 137 0.7× 187 1.2× 25 1.1k
Trent Anderson United States 18 445 0.4× 401 0.6× 146 0.7× 201 1.0× 54 0.3× 31 969
Ji E. Lee South Korea 17 769 0.6× 215 0.3× 244 1.1× 98 0.5× 116 0.7× 27 1.1k
Lothar Burghaus Germany 20 707 0.6× 385 0.5× 258 1.2× 292 1.4× 165 1.0× 61 1.5k

Countries citing papers authored by Paul Morrish

Since Specialization
Citations

This map shows the geographic impact of Paul Morrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Morrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Morrish more than expected).

Fields of papers citing papers by Paul Morrish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Morrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Morrish. The network helps show where Paul Morrish may publish in the future.

Co-authorship network of co-authors of Paul Morrish

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Morrish. A scholar is included among the top collaborators of Paul Morrish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Morrish. Paul Morrish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Michael, Jasmine Wall, Catherine J. Mummery, et al.. (2022). Numbers and types of neurological emergencies in England and the influence of socioeconomic deprivation: a retrospective analysis of hospital episode statistics data. BMJ Open. 12(11). e061843–e061843. 4 indexed citations
2.
Morrish, Paul, Susan Duncan, & Hannah R. Cock. (2019). Epilepsy deaths: Learning from health service delivery and trying to reduce risk. Epilepsy & Behavior. 103(Pt B). 106473–106473. 6 indexed citations
3.
Morrish, Paul, et al.. (2018). Acute hepatitis E infection as a cause of unexplained neurological symptoms. BMJ Case Reports. 2018. bcr–2018. 2 indexed citations
4.
Morrish, Paul. (2012). Prescribing in Parkinson's disease: a story of hope and adverse events. Practical Neurology. 12(5). 335–340. 9 indexed citations
5.
Morrish, Paul. (2012). A massage from Queen Square. Practical Neurology. 12(6). 395–395.
6.
Morrish, Paul. (2009). The changing relationship between neurology and general practice in the UK. British Journal of General Practice. 59(565). 599–604. 6 indexed citations
7.
Morrish, Paul. (2009). Coma in 20 Questions. Practical Neurology. 9(1). 33–36.
8.
Morrish, Paul. (2003). How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?. Movement Disorders. 18(S7). S63–S70. 56 indexed citations
9.
Rakshi, James S., Nicola Pavese, Takeshi Uema, et al.. (2002). A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18 F-dopa PET study. Journal of Neural Transmission. 109(12). 1433–1443. 47 indexed citations
10.
Morrish, Paul. (2002). Is it time to abandon functional imaging in the study of neuroprotection?. Movement Disorders. 17(2). 229–232. 18 indexed citations
11.
Davies, Jeffrey S., Paul Morrish, & M. F. Scanlon. (2001). Graves’ disease presenting as hemiparkinsonism. Journal of Endocrinological Investigation. 24(3). 188–189. 5 indexed citations
12.
Rakshi, James S., Takeshi Uema, Kengo Ito, et al.. (1999). Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study. Brain. 122(9). 1637–1650. 225 indexed citations
13.
Ito, Kengo, Paul Morrish, James S. Rakshi, et al.. (1999). Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. 66(6). 754–758. 49 indexed citations
14.
Wenning, Gregor K., Per Odin, Paul Morrish, et al.. (1997). Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Annals of Neurology. 42(1). 95–107. 272 indexed citations
15.
Piccini, Paola, Paul Morrish, N. Turjanski, et al.. (1997). Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography study. Annals of Neurology. 41(2). 222–229. 100 indexed citations
16.
Rabey, Jose M., Ubaldo Bonuccelli, David J. Brooks, et al.. (1997). Evaluation of the Short Parkinsonʼs Evaluation Scale. Clinical Neuropharmacology. 20(4). 322–337. 47 indexed citations
17.
Morrish, Paul. (1997). Parkinson's disease is not a long‐latency illness. Movement Disorders. 12(6). 849–854. 10 indexed citations
18.
Morrish, Paul, G. V. Sawle, & David J. Brooks. (1996). An [18F]dopa–PET and clinical study of the rate of progression in Parkinson’s disease. Brain. 119(2). 585–591. 290 indexed citations
19.
Morrish, Paul, G. V. Sawle, & David J. Brooks. (1996). Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. Brain. 119(6). 2097–2103. 125 indexed citations
20.
Sawle, G. V., David J. Burn, Paul Morrish, et al.. (1994). The effect of entacapone (OR‐611) on brain [ 18 F]‐6‐L‐fluorodopa metabolism. Neurology. 44(7). 1292–1292. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ihtsham Haq Breakdown of academic impact, for papers by Christopher Kenney Breakdown of academic impact, for papers by Lorenzo Kiferle Breakdown of academic impact, for papers by E.M.J. Foncke Breakdown of academic impact, for papers by Hisao Tachibana Breakdown of academic impact, for papers by Samer D. Tabbal Breakdown of academic impact, for papers by R. Hilker Breakdown of academic impact, for papers by Trent Anderson Breakdown of academic impact, for papers by Ji E. Lee Breakdown of academic impact, for papers by Lothar Burghaus
Rankless by CCL
2026